Screener
GeneDx Holdings WGS Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by GeneDx Holdings in its filing.
Tagged under the XBRL concept us-gaap:MarketableSecuritiesCurrent.
The source filing: GeneDx Holdings’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001818331-26-000041
| Line item | March 31, 2026 (Unaudited) | December 31, 2025 |
|---|---|---|
| Assets: | ||
| Current assets: | ||
| Cash and cash equivalents | $93,924 | $104,997 |
| Marketable securities | 76,761 | 66,285 |
| Accounts receivable | 76,929 | 74,370 |
| Inventory, net | 12,241 | 13,951 |
| Prepaid expenses and other current assets | 10,774 | 8,685 |
| Total current assets | 270,629 | 268,288 |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is GeneDx Holdings's short-term investments?
- GeneDx Holdings (WGS) reported short-term investments of $76.76M in Q1 2026.
- How has GeneDx Holdings's short-term investments changed year-over-year?
- GeneDx Holdings's short-term investments increased by 29.1% year-over-year, from $59.46M to $76.76M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.
Ask your AI about GeneDx Holdings's short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude